Loading
Latest filing published 03 Sept 2025 for CLINICA BAVIERA, S.A., €21k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Luis Baviera Diaz Leante is a declared insider of Clinica Baviera, S.A., with filings sourced from CNMV. The record holds 6 filings, for trades running from 11 October 2022 to 29 August 2025.
On the open market, the record shows 5 purchases worth €25k and 1 sale worth €21k. On balance, insiders were net buyers of €4,553. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2025: no purchases and 1 sale on the market.
A typical purchase (the median) is worth €4,994. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 3 September 2025: an open-market sale of €21k, in Clinica Baviera, S.A. The last insider purchase was made public on 5 June 2023, 1,237 days ago. Filings reach the CNMV feed a median of 4 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by CNMV and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations